Genotyping:The predictive power of haplotypes in clinical response
- 1 February 2000
- journal article
- review article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 1 (1) , 15-26
- https://doi.org/10.1517/14622416.1.1.15
Abstract
A variety of approaches have been proposed to find genetic markers that can be used in a clinical setting. Single nucleotide polymorphisms (SNPs) are the basis of the most commonly used approaches. Here we describe an approach using gene-based haplotypes, which are collections of SNPs located throughout the ftinctional regions of candidate genes, and organised as they occur separately on an individual's two chromosomes. The main point of this review is that the haplotype has greater power than any individual SNP to track an unobsenrved, but evolutionarily linked, variable site.Keywords
This publication has 29 references indexed in Scilit:
- The DNA sequence of human chromosome 22Nature, 1999
- Complex traits, genes, polymorphisms and the drug discovery/development processCurrent Opinion in Biotechnology, 1999
- Single nucleotide polymorphism libraries: why and how are we building them?Molecular Medicine Today, 1999
- The science of pharmacological variability: An essayClinical Pharmacology & Therapeutics, 1999
- Characterization of single-nucleotide polymorphisms in coding regions of human genesNature Genetics, 1999
- Patterns of single-nucleotide polymorphisms in candidate genes for blood-pressure homeostasisNature Genetics, 1999
- Drug Firms to Create Public Database of Genetic MutationsScience, 1999
- Haplotype Structure and Population Genetic Inferences from Nucleotide-Sequence Variation in Human Lipoprotein LipaseAmerican Journal of Human Genetics, 1998
- DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase geneNature Genetics, 1998
- Estimation of myriad haplotype frequenciesGenetic Epidemiology, 1985